Document is current

Article History

Received: 15 October 2024

Accepted: 29 October 2024

First Online: 13 November 2024

Disclosure

: Oluwadamilola M. Fayanju has received research support from Gilead Sciences, Inc. that is outside the scope of this work. Chantal Reyna has received an honoraria from Elucent Medical that is outside the scope of this work and the relationship has been terminated. Anna Weiss reports the following disclosures: advisory board/consulting fees from Merck and Myriad Laboratories, Inc.; honoraria from the Society of Breast Imaging, MJH Lifesciences, and Breast Cancer Foundation New Zealand; food and beverage from Endomag. Judy C. Boughey receives funding, paid to her institution, from Eli Lilly and SymBioSis, and sits on the Data Safety Monitoring Committee of Cairns Surgical. She has received honoraria from PER, PeerView, OncLive, EndoMag, and Up-To-Date. Andrea V. Barrio has received a speaking honorarium from Novartis. Jennifer K. Plichta serves on a committee for the National Comprehensive Cancer Network. She has received grant funding from Earlier.org that is outside the scope of this work, and has received honoraria from the National Consortium of Breast Centers. Marie Catherine Lee is a paid consultant for Elucent Medical and Provepharm. Puneet Singh, Doreen M. Agnese, Miral Amin, Astrid Botty van den Bruele, Erin E. Burke, David N. Danforth Jr, Frederick M. Dirbas, Firas Eladoumikdachi, Olga Kantor, Shicha Kumar, Cindy Matsen, Toan T. Nguyen, Tolga Ozmen, Ko Un Park, Shayna L. Showalter, Toncred Styblo, Nicholas Tranakas, Ashley Woodfin, and Christine Laronga have no conflicts of interest to declare that may be relevant to the contents of this work.